| Event Time: | Monday March 18, 2013 2:00 pm to 6:00 pm |
| Topic(s): | Aging/Dementia/Degenerative Disease, Subspecialty in Focus |
| Director(s): | Norman Foster MD, FAAN |
| Description: | Amyloid PET imaging has recently been approved by the FDA. Neurologists will need to know how to best utilize this exciting new technology. This program will establish the knowledge base for understanding how neurologists can optimally utilize amyloid imaging in clinical practice. It will include individuals involved in developing recommendations about the use of amyloid PET imaging, nuclear medicine physicians knowledgeable about the technical aspects of amyloid imaging and communicating with referring physicians, neurologists involved in the day-to-day care of patients with neurocognitive disorders and familiar with amyloid PET imaging, and a bioethicist to discuss the ethical issues involved in amyloid PET imaging including scanning of asymptomatic individuals and non-medical uses. This will culminate in the presentation of cases representing the range of clinical circumstances when physicians and patients might consider amyloid imaging. This program is offered in partnership with the Society for Nuclear Medicine and Molecular Imaging and the AAN Geriatric Neurology Section. |
| Completion Message: | Participants should understand when amyloid PET imaging is appropriate and inappropriate, be able to identify when amyloid PET results are reliable and when they may be misleading, be able to incorporate amyloid PET scan results to increase diagnostic confidence and accuracy of cognitive evaluations, and consider ethical issues when talking to patients about amyloid PET imaging. |
| Program Venue: | HC. Half-Day Course |
| CME Credits: | 3.5 |
| Core Competencies: | Interpersonal and Communication Skills, Medical Knowledge, Patient Care, Practice-Based Learning and Improvement, Professionalism, Systems-Based Practice |
| Start/End Time | Title | Faculty |
|---|---|---|
| 2:00 PM - 2:15 PM | Introduction | Norman Foster MD, FAAN |
| 2:15 PM - 3:15 PM | Appropriate and Inappropriate Use Recommendations for Clinical Amyloid PET | Keith Johnson MD |
| 3:15 PM - 4:15 PM | Technical Issues, Communicating with Nuclear Medicine Physicians, and Reimbursement | John Hoffman MD |
| 4:15 PM - 4:30 PM | Break | None |
| 4:30 PM - 5:00 PM | Ethical Considerations in Using Amyloid Imaging | Jason Karlawish MD |
| 5:00 PM - 6:00 PM | Discussion of Cases with Audience and Faculty: To Scan or Not to Scan | Norman Foster MD, FAAN |
| Half-Day Course (8:00 AM-12:00 PM) | ||
|---|---|---|
| 1HC.003 | Primer of Behavioral Neurology | Bradford Dickerson MD |
| Seminar (4:00 PM-6:00 PM) | ||
| 1SM.003 | Mild Cognitive Impairment: Implications for Clinicians | Neill Graff-Radford MD, FAAN |
| Seminar (6:30 AM-8:30 AM) | ||
|---|---|---|
| 2SM.004 | What Neurologists Really Need to Know About Normal Pressure Hydrocephalus | Michael Williams MD, FAAN |
| Half-Day Course (9:00 AM-1:00 PM) | ||
| 2HC.001 | Clues to Synuclein Spread in Parkinson's Disease | Kathleen Shannon MD |
| Full-Day Course (10:00 AM-6:00 PM) | ||
| 2FC.003 | Dementia Update | Bradley Boeve MD |
| Half-Day Course (2:00 PM-6:00 PM) | ||
| 2HC.005 | Leukodystrophies | Adeline Vanderver MD |
| Integrated Neuroscience (8:00 AM-12:00 PM) | ||
|---|---|---|
| 3IN.001 | Alzheimer's Biomarkers in Clinical Practice | Douglas Galasko MD, Gil Rabinovici MD |
| Half-Day Course (9:00 AM-1:00 PM) | ||
| 3HC.001 | The Visual and Ocular Motor Systems in Neurodegenerative and Genetic Disease | David Zee MD, FAAN |
| Scientific Poster Session (2:00 PM-6:30 PM) | ||
| 3PS.001 | Poster Session 1 | |
| Seminar (6:30 AM-8:30 AM) | ||
|---|---|---|
| 4SM.001 | Differential Diagnosis of Dementia: Linking Clinical Syndromes to Biomarkers | Jeffrey Burns MD |
| Scientific Platform Session (1:00 PM-2:45 PM) | ||
| 4SS.004 | Amyloid Imaging in the Prediction of and Diagnosis of Alzheimer's Disease | |
| Integrated Neuroscience (1:00 PM-5:00 PM) | ||
| 4IN.001 | Global Impact of Non-communicable Neurological Diseases | Massimo Pandolfo MD, Jerome Chin MD, PhD, MPH |
| Half-Day Course (1:00 PM-5:00 PM) | ||
| 4HC.004 | Assessment of Rapidly Progressive Dementias and Related Neurologic Conditions | Steven Vernino MD, PhD, FAAN |
| Scientific Poster Session (2:00 PM-6:30 PM) | ||
| 4PS.003 | Poster Session 3 | |
| Scientific Poster Session (7:30 AM-12:00 PM) | ||
|---|---|---|
| 5PS.004 | Poster Session 4 | |
| Scientific Platform Session (2:00 PM-3:45 PM) | ||
| 5SS.024 | Aging and Dementia: Epidemiology and Clinical Science | |
| Scientific Poster Session (2:00 PM-7:00 PM) | ||
| 5PS.005 | Poster Session 5 | |
| Scientific Platform Session (4:00 PM-5:30 PM) | ||
| 5SS.034 | Aging and Dementia: Genetics and Biochemical Markers | |
| Scientific Poster Session (7:30 AM-12:00 PM) | ||
|---|---|---|
| 6PS.006 | Poster Session 6 | |
| Scientific Platform Session (12:00 PM-1:45 PM) | ||
| 6SS.044 | Aging and Dementia: Imaging and Neuropathology | |
| Integrated Neuroscience (12:00 PM-4:00 PM) | ||
| 6IN.001 | Toward a Dimorphic Neurology: Implications for Men's and Women's Health | Walter Rocca MD, MPH, Mark Mehler MD, FAAN |
| Half-Day Course (12:00 PM-4:00 PM) | ||
| 6HC.005 | Cumulative Sports Concussion and Risk of Dementia | Barry Jordan MD |
| Scientific Poster Session (2:00 PM-7:00 PM) | ||
| 6PS.007 | Poster Session 7 | |
| Extended Seminar (6:00 PM-9:00 PM) | ||
| 6ES.003 | Case Studies: Dementia | Jody Corey-Bloom MD, PhD |
| Morning Report (6:30 AM-8:00 AM) | ||
|---|---|---|
| 7MR.001 | Morning Report: Behavioral Neurology | Brandy Matthews MD |
| Extended Seminar (6:30 AM-9:30 AM) | ||
| 7ES.001 | Ethics, Clinical Practice, and Challenges in Neurogeriatric Care for the 21st Century | Jerome Kurent MD, MPH, FAAN |
| Integrated Neuroscience (8:00 AM-12:00 PM) | ||
| 7IN.001 | Inflammation in Epilepsy | Jacqueline French MD, FAAN, Tallie Baram MD, PhD |
| Half-Day Course (8:00 AM-12:00 PM) | ||
| 7HC.001 | Neurorehabilitation Enhancement Techniques | Randolph Marshall MD, FAAN |
| Integrated Neuroscience (1:00 PM-5:00 PM) | ||
| 7IN.003 | Brain Stimulation: Clinical and Neuroscience Implications | Anjan Chatterjee MD, FAAN, H. Coslett MD, FAAN |
| Half-Day Course (1:00 PM-5:00 PM) | ||
| 7HC.016 | Non-Alzheimer's Dementia | Michael Geschwind MD, PhD |
| 7HC.010 | Epilepsy Co-morbidities | William Theodore MD, FAAN |
| Seminar (6:30 AM-8:30 AM) | ||
|---|---|---|
| 8SM.001 | Bladder Leaks, Sweats, Drools, Sadness and Other Nonmotor Parkinson's disease Symptoms: How to Recognize and Treat? | Ronald Pfeiffer MD, FAAN |
| Extended Seminar (6:30 AM-9:30 AM) | ||
| 8ES.002 | Improving Accuracy of Dementia Diagnosis: Case Studies with Both Imaging and Neuropathology | James Leverenz MD, FAAN |